Skip to main content

American Thoracic Society

Events
Search
Sign Up
Sign In

Item Added to Cart

You just added

You have item(s) in your cart

  • Proceed to Checkout

Adempas for PAH-CHD

  • Overview
  • Resources

Thank you

This live web event has ended. Thank you for attending.

Description

PAH-CHD is the second most common form of associated PAH in adults. PAH-CHD subgroup data from Patent-1 study including change in 6MWD, WHO FC, PVR and NT-
pro-BNP data from baseline to week 12 will be presented.

This webinar is Sponsored by Bayer Healthcare.

By registering for this webinar, you agree your information will be shared with the sponsor.

No CME or MOC credits are available for this program.

Opinions expressed and resources shared may not have been reviewed by the ATS prior to distribution through ATS channels, or reflect official positions of the ATS, unless it is explicitly noted as a result of official ATS approval. References to specific commercial entities (companies) or products do not reflect review or endorsement by the ATS unless it is explicitly noted as a result of official ATS approval.


Contributors

  • Richard A. Krasuski, MD

    •Director of the Adult Congenital Heart Center at Duke University Medical Center, the Director of Hemodynamic Research and the Medical Director of the CTEPH Program
    •Professor of Medicine and Pediatrics at Duke
    •Received medical degree from Harvard and completed a residency in internal medicine at Brigham & Women’s Hospital and a cardiology fellowship at Duke
    •Has authored or co-authored >350 peer-reviewed articles, abstracts and book chapters

  • PAH-CHD | Adempas US HCP Nov19 (adempashcp.com)

    https://www.adempashcp.com/?refresh=

August 10, 2022
Wed 6:30 PM EDT

Duration 1H 0M

This live web event has ended.

For Technical Support
support@blueskyelearn.com
+1 (858) 201-4136
Register
Log In
  • New
  • Existing

Forgot password?
  • Events
  • Search
  • Support
  • Sign Up
  • Sign In
  • Privacy Policy | Cookies Policy